Alternative Receptors for HIV-1 in Nervous System Tissues

[1]  M. Tristem,et al.  A highly divergent retroviral sequence in the tuatara (Sphenodon). , 1995, Virology.

[2]  R. Doms,et al.  Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide , 1994, Journal of virology.

[3]  J. Fantini,et al.  Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. , 1994, Virology.

[4]  J. Sodroski,et al.  Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies , 1994, Journal of virology.

[5]  E. Jacotot,et al.  T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. , 1993, Science.

[6]  G. Rosoklija,et al.  The gp 120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons , 1993, Annals of neurology.

[7]  F E Bloom,et al.  Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Harrington,et al.  Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line , 1993, Journal of virology.

[9]  S. Snyder,et al.  Human cortical neuronal cell line: a model for HIV-1 infection in an immature neuronal system. , 1993, AIDS research and human retroviruses.

[10]  J. Fantini,et al.  Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Levy,et al.  Infection of cultured human adrenal cells by different strains of HIV , 1992, AIDS.

[12]  U. Walter,et al.  HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. , 1992, Virology.

[13]  H. Moreau,et al.  Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells , 1992, Journal of virology.

[14]  C. Kufta,et al.  Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism , 1992, Journal of virology.

[15]  A. Burny,et al.  Infection of human brain cells by HIV‐1: restricted virus production in chronically infected human glial cell lines , 1992, AIDS.

[16]  D. Volsky,et al.  A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation. , 1992, Virology.

[17]  E. Major,et al.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta , 1991, Journal of virology.

[18]  D. Silberberg,et al.  Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Hendrickson,et al.  CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. , 1991, Current opinion in biotechnology.

[20]  D. Silberberg,et al.  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. , 1991, Science.

[21]  Y. Masuho,et al.  In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. , 1991, Journal of immunology.

[22]  H. Friedman,et al.  Entry of Human Immunodeficiency Virus‐1 Into Glial Cells Proceeds via an Alternate, Efficient Pathway , 1991, Journal of leukocyte biology.

[23]  H. Gendelman,et al.  HIV Replication and Persistence in Human Gastrointestinal Cells Cultured In Vitro , 1991, Journal of leukocyte biology.

[24]  C. Kufta,et al.  Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent , 1991, Journal of virology.

[25]  L. Montagnier,et al.  Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infection , 1991, Annals of neurology.

[26]  H. Friedman,et al.  Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor , 1990, Journal of virology.

[27]  Reed J. Harris,et al.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.

[28]  R. Kurth,et al.  Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVagm. , 1990, AIDS.

[29]  D. Ho,et al.  CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro , 1990, Journal of virology.

[30]  B. Chesebro,et al.  Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells , 1990, Journal of virology.

[31]  C. Kunsch,et al.  Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope , 1989, Journal of virology.

[32]  J. Weber,et al.  Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. , 1989, The Journal of general virology.

[33]  F. Kitame,et al.  A human melanoma cell line highly susceptible to influenza C virus. , 1989, The Journal of general virology.

[34]  J. Levy,et al.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Hoxie,et al.  CD4-independent infection of human neural cells by human immunodeficiency virus type 1 , 1989, Journal of Virology.

[36]  A. Dalgleish,et al.  Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells , 1989, Nature.

[37]  S. Matsushita,et al.  Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope , 1988, Journal of virology.

[38]  S. Dewhurst,et al.  Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV , 1987, Journal of virology.

[39]  G. Nakamura,et al.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.

[40]  R. Guyton,et al.  Human immunodeficiency virus infection of the developing human nervous system. , 1987, Virology.

[41]  C. Cheng‐Mayer,et al.  Human immunodeficiency virus can productively infect cultured human glial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Chiodi,et al.  Infection of brain-derived cells with the human immunodeficiency virus , 1987, Journal of virology.

[43]  Q. Sattentau,et al.  Epitopes of the CD4 antigen and HIV infection. , 1986, Science.

[44]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[45]  W H Woolley,et al.  Theoretical biology and biophysics , 1971 .